Peer-reviewed veterinary case report
Survival and response in cats with nasal cancer after palliative
By Giuliano, Antonio & Dobson, Jane·Published in Journal of Feline Medicine and Surgery·2020·Department of Veterinary Medicine, University of Cambridge, Cambridge, UK, United Kingdom·View original on Crossref →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical response and survival time of cats with carcinoma of the nasal cavity treated with palliative coarse fractionated radiotherapy
- Species:
- cat
Plain-English summary
A group of 28 cats with nasal cavity cancer (carcinoma) received palliative coarse fractionated radiotherapy to help relieve their symptoms. Most of the cats showed improvement in their clinical signs, and the average survival time was about 342 days. However, cats with more advanced stages of cancer or facial deformities had shorter survival times. The treatment was generally well-tolerated, with only mild side effects like hair loss reported. Overall, this type of radiotherapy can be effective for managing symptoms and extending life in cats with this condition.
People also search for: cat nasal cancer treatment · palliative care for cats · feline carcinoma survival rate · radiotherapy side effects in cats · cat cancer symptoms and treatment
Abstract
Objectives Carcinoma is the second most common tumour of the nasal cavity in cats. Few studies assessing the response and survival of cats with carcinoma of the nasal cavity treated with palliative coarse fractionated radiotherapy have been published. Methods Twenty-eight cats were diagnosed with histologically confirmed carcinoma of the nasal cavity. All patients treated with a coarse fractionated radiotherapy protocol were retrospectively reviewed. Results Improvement of the clinical signs were reported in 24 cases; median survival time (MST) was 342 days; and cats with Adams modified stage IV and facial deformity had a significantly reduced MST of 152 days ( P = 0.0013) and 67 days ( P = 0.0002), respectively. Severe radiotherapy-related clinical signs were not reported and alopecia and leukotrichia were the most common side effects reported in ten cases. Conclusions and relevance Coarse fractionated radiotherapy treatment for carcinoma of the nasal cavity in cats is effective in relieving clinical signs. Long survival times can be achieved, in particular in cases with a less advanced stage of the tumour.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Crossref: https://doi.org/10.1177/1098612x19893445